An independent report has been released today by Stevenage Bioscience Catalyst (SBC) that demonstrates its key role in delivering economic benefit from life sciences research and innovation in the UK.
The award win recognizes Nanoform as a listed company that places innovation at the center of its strategy for business development and introduces an innovative technology to the market.
While batch process chemistry remains the standard in the pharmaceutical industry, a clear increase in continuous flow processes has emerged over the past decade thanks to the commercialization of preparative flow reactor units. I
15 start-ups with huge potential have successfully completed the Data-driven Advanced Therapeutics Accelerator (DATA) programme at Stevenage Bioscience Catalyst (SBC), one of Europe’s most important science parks for life sciences.
Nanoform, an innovative nanoparticle medicine enabling company, today announced it has received ISO/IEC 27001:2013 certification for its Information Security Management System (ISMS).
Not long now - #BioIntegrates is tomorrow and we're excited to be back in person!
We have an excellent line-up of interviews, innovator sessions, & panel discussions covering the most current questions facing the #biopharmaceutical sector. See you tomorrow!
#lifescience #pharma
How do you prepare your regulatory strategy to enable a rapid route to market? Join us at MedTech Integrates where James Fry, @MillsandReeve, will discuss this with confirmed panellists from @UK_ABHI, @perfectusbiomed & @YHEC1
https://www.lifescienceintegrates.com/medtech-integrates-2022/
#medtech #regulations
Discover how @YSDS_UK is combining technology with human service to move the world’s most valuable goods to any location with exceptional service and care
Talk to their expert team at #BioIntegrates at YSDS Life Science booth 1